Several GWAS and candidate gene studies have identified that RTEL1 variants are associated with cancer genetic susceptibility, including lung cancer, breast cancer, gastric cancer, colorectal cancer, and esophageal cancer [49]. This evidence concerns the gene RTEL1 and esophageal cancer.